Earlier research on coumarin showed very promising results, but some of the in vivo studies using rodents showed toxicity, which was discovered to be a metabolic pathway that is not usual in humans. But the compound was taken off the market in a number of countries, which is a real shame since it is one of the few and only pharmacological approaches that has shown success in reducing protein accumulation. If you are doing research in this area, please contact me.
Thanks,
Elaine Weil, NP